1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

GluBio Pharmaceutical Co., Ltd.

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2020

Location

Hangzhou Zhejiang China

Primary Industry

Pharmaceuticals

About

Established in 2020 and based in Hangzhou, China, GluBio Pharmaceutical Co., Ltd. operates as a drug developer that focuses on the research and development of molecular gel targeted protein degradation drugs. Gang Lu and Liqiang Fu are the founder of the company. 80% employees of the core research team has doctor's degree. The company established R & D center located in San Diego, California, USA and Zhangjiang, Shanghai. The company provides molecular gel drugs. The company focuses on the research and development of small molecule protein antidotes. The company's products include molecular glue and PROTAC medicine. The company develops multi dimensional protein degradation screening platform, innovative target verification platform, molecular gel rational design platform, and proprietary high activity molecular library. The company's products can treat recurrent and refractory hematoma. In July 2022, the company will plan to layout and establish R & D pipeline, upgrade drug development platform
Current Investors
Qiming Venture Partners, Lilly Asia Ventures, Kaitai Capital

Request a demo to show more

Primary Industry
Pharmaceuticals
Sub Industries
Diagnostic, Medical & Imaging Laboratories, Pharmaceutical Research & Development
Verticals
HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.